Related Experiment Video
Updated: Mar 19, 2026

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro
Published on: April 21, 2023
Evaluation and study of antimicrobial activity of nanoliposomal meropenem against Pseudomonas aeruginosa isolates
Momeni-Javid Zahra1, Hamishekar Hamed2, Rahmati-Yamchi Mohammad1,2
1a Department of Medical Biotechnology, Faculty of Advanced Medical Science , Tabriz University of Medical Science , Tabriz , Iran.
Background:
The aim of this study was to evaluate the antimicrobial efficacy of liposomal meropenem formulation against clinical and laboratory isolates of Pseudomonas aeruginosa. P. aeruginosa isolates were used to determine the MIC and MBC of free and liposomal meropenem. As well as the effect of free and liposomes meropenem compare the minimum biofilm eradication concentration and inhibition of P. aeruginosa motility was assessed.
Results:
In this study, the MICs and MBC of liposomal meropenem was more effective against all clinical and laboratory strains were significantly lower than those of free meropenem (6.25 μg/ml vs 100 μg/ml). Furthermore, liposomal meropenem (≥1.5 μg/ml) completely eradicated biofilm in all P. aeruginosa isolates. While the free form of drug could eradicate biofilm formation in most of isolates in ≥6.25 μg/ml concentration. In addition, lower concentrations of liposomal meropenem could inhibit the bacterial motility.
Conclusion:
The results clearly indicate that the liposomal formulation of drug is more effective than meropenem alone against antibiotic resistant P. aeruginosa isolates.
Insights
Liposomal meropenem demonstrates superior antimicrobial efficacy against Pseudomonas aeruginosa, significantly reducing minimum inhibitory and bactericidal concentrations. This novel formulation also effectively eradicates biofilms and inhibits bacterial motility.
Area of Science:
- Microbiology
- Pharmaceutical Sciences
- Drug Delivery Systems
Background:
- Pseudomonas aeruginosa is a significant opportunistic pathogen.
- Antibiotic resistance in P. aeruginosa poses a major clinical challenge.
- Novel drug delivery systems are needed to enhance antimicrobial efficacy.
Purpose of the Study:
- To evaluate the antimicrobial efficacy of liposomal meropenem against P. aeruginosa.
- To compare liposomal meropenem with free meropenem.
- To assess the impact on biofilm eradication and bacterial motility.
Main Methods:
- Determined Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC).
- Assessed Minimum Biofilm Eradication Concentration (MBEC).
- Evaluated inhibition of P. aeruginosa motility.
Main Results:
- Liposomal meropenem showed significantly lower MICs and MBCs compared to free meropenem (6.25 μg/ml vs 100 μg/ml).
- Liposomal meropenem completely eradicated P. aeruginosa biofilms at concentrations as low as ≥1.5 μg/ml.
- Lower concentrations of liposomal meropenem inhibited bacterial motility more effectively than the free form.
Conclusions:
- Liposomal meropenem is more effective than meropenem alone against antibiotic-resistant P. aeruginosa.
- Liposomal formulation enhances meropenem's activity against P. aeruginosa.
- This formulation holds promise for treating P. aeruginosa infections.
More Related Videos
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Antimicrobial Effectiveness
Gene Regulation in Microbial Communities: Quorum Sensing
Inhibitors of Gram-positive Cell Wall Synthesis
Mechanism of Antibiotic Resistance in MRSA
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...

